200 Notice regarding Review of regulatory regime for drug approval 2021-Oct-14 348 KB
F. No. 12-01/21-DC (Pt-306 — XXXVI- MDTL) Government of India : Directorate General of Health Services Central Drugs Standard Control Organization (New Drugs Division)
Notice
FDA Bhavan, Kotla Road, New Delhi ; Dated: 19 4 OCT Wi .
Subject: Review of regulatory regime for drug approval — Reg
In order toenhancth e testing capacity of medical devices in the country identification ‘registration& empanelment of government private testing laboratories for medical - device testing is under consideration as permedical devices Rules, 2017. “In thisregards, laboratories which have capacity for testing of medical devices & are _ NABL accredited & interested in above process are requested tointimate the same to of categories ~ CDSCO atdci@edsco.nic.in& ddcimd-cdsco@nic in along with details of such medical devices and capacities & capabilities of testing to CDSCO for tt a ee - . - initiatingCancecee te SRfurtherSs examination(0 rr desion and communication in this regard . erea a, 7 a : oe r ™ - P vw t ‘ Drugs Controller General (India) | : nCDSCO website " oe4S e nil he SeasL a :
Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.
No analysis has been generated for this document yet.